{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T21:52:25Z","timestamp":1792878745066,"version":"4.5.0"},"reference-count":48,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T00:00:00Z","timestamp":1742169600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["STR1095\/6-1"],"award-info":[{"award-number":["STR1095\/6-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["SFB 1382"],"award-info":[{"award-number":["SFB 1382"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["403224013"],"award-info":[{"award-number":["403224013"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008322","name":"CSL Behring","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007210","name":"RWTH Aachen University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007210","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009398","name":"RWTH Aachen University Medical Faculty","doi-asserted-by":"publisher","award":["PTD 1-3"],"award-info":[{"award-number":["PTD 1-3"]}],"id":[{"id":"10.13039\/501100009398","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jhep-reports.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JHEP Reports"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.jhepr.2025.101398","type":"journal-article","created":{"date-parts":[[2025,3,20]],"date-time":"2025-03-20T07:04:35Z","timestamp":1742454275000},"page":"101398","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Severe alpha-1 antitrypsin deficiency is associated with a higher risk of complications after first decompensation than other aetiologies of cirrhosis"],"prefix":"10.1016","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6708-3061","authenticated-orcid":false,"given":"Lorenz","family":"Balcar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0382-5705","authenticated-orcid":false,"given":"Malin","family":"Fromme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4614-1477","authenticated-orcid":false,"given":"Naomi","family":"Kappe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8690-2774","authenticated-orcid":false,"given":"Benedikt","family":"Schaefer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1462-5920","authenticated-orcid":false,"given":"So\u0148a","family":"Fra\u0148kov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lukas","family":"van Melkebeke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7887-386X","authenticated-orcid":false,"given":"Jan","family":"Stolk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathias","family":"Jachs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0411-166X","authenticated-orcid":false,"given":"Georg","family":"Semmler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3403-3372","authenticated-orcid":false,"given":"Benedikt S.","family":"Hofer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tammo L.","family":"Tergast","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Rieland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Sophie","family":"Karl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8619-2610","authenticated-orcid":false,"given":"Jan","family":"Sperl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00f2nica","family":"Pons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harald","family":"Hofer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0597-2728","authenticated-orcid":false,"given":"Markus","family":"Peck-Radosavljevic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Trauner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Reiberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3250-3177","authenticated-orcid":false,"given":"Benjamin","family":"Maasoumy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heinz","family":"Zoller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart","family":"van Hoek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jef","family":"Verbeek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7122-6379","authenticated-orcid":false,"given":"Pavel","family":"Strnad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2330-0017","authenticated-orcid":false,"given":"Mattias","family":"Mandorfer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.jhepr.2025.101398_bib1","first-page":"934","article-title":"Cirrhosis associated with alpha-1-antitrypsin deficiency: a previously unrecognized inherited disorder","volume":"73","author":"Sharp","year":"1969","journal-title":"J Lab Clin Med"},{"issue":"12","key":"10.1016\/j.jhepr.2025.101398_bib2","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1056\/NEJM198603203141202","article-title":"Risk of cirrhosis and primary liver cancer in alpha 1-antitrypsin deficiency","volume":"314","author":"Eriksson","year":"1986","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.jhepr.2025.101398_bib3","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.jhep.2016.03.010","article-title":"Update on alpha-1 antitrypsin deficiency: new therapies","volume":"65","author":"Lomas","year":"2016","journal-title":"J Hepatol"},{"issue":"2","key":"10.1016\/j.jhepr.2025.101398_bib4","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1053\/j.gastro.2020.06.035","article-title":"Is heterozygosity for the alpha-1 antitrypsin risk allele Pi\u2217MZ a disease modifier or genetic risk factor?","volume":"159","author":"Zoller","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhepr.2025.101398_bib5","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2016.51","article-title":"\u03b11-Antitrypsin deficiency","volume":"2","author":"Greene","year":"2016","journal-title":"Nat Rev Dis Primers"},{"issue":"15","key":"10.1016\/j.jhepr.2025.101398_bib6","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1056\/NEJMra1910234","article-title":"Alpha(1)-Antitrypsin deficiency","volume":"382","author":"Strnad","year":"2020","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.jhepr.2025.101398_bib7","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1136\/gutjnl-2020-323729","article-title":"Hepatobiliary phenotypes of adults with alpha-1 antitrypsin deficiency","volume":"71","author":"Fromme","year":"2022","journal-title":"Gut"},{"issue":"3","key":"10.1016\/j.jhepr.2025.101398_bib8","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1053\/j.gastro.2019.05.013","article-title":"Liver fibrosis and metabolic alterations in adults with alpha-1-antitrypsin deficiency caused by the Pi\u2217ZZ mutation","volume":"157","author":"Hamesch","year":"2019","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.jhepr.2025.101398_bib9","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1007\/s11901-019-00469-x","article-title":"Hepatic venous pressure gradient response in non-selective beta-blocker treatment\u2014is it worth measuring?","volume":"18","author":"Mandorfer","year":"2019","journal-title":"Curr Hepatol Rep"},{"issue":"2","key":"10.1016\/j.jhepr.2025.101398_bib10","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1053\/j.gastro.2020.04.058","article-title":"Liver phenotypes of European adults heterozygous or homozygous for Pi\u2217Z variant of AAT (Pi\u2217MZ vs Pi\u2217ZZ genotype) and noncarriers","volume":"159","author":"Schneider","year":"2020","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.jhepr.2025.101398_bib11","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1136\/gutjnl-2018-316228","article-title":"Heterozygous carriage of the alpha1-antitrypsin Pi\u2217Z variant increases the risk to develop liver cirrhosis","volume":"68","author":"Strnad","year":"2019","journal-title":"Gut"},{"issue":"10","key":"10.1016\/j.jhepr.2025.101398_bib12","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1111\/apt.17715","article-title":"Liver disease progression in patients with alpha-1 antitrypsin deficiency and protease inhibitor ZZ genotype with or without lung disease","volume":"58","author":"Wu","year":"2023","journal-title":"Aliment Pharmacol Ther"},{"issue":"11","key":"10.1016\/j.jhepr.2025.101398_bib13","article-title":"Alpha-1 antitrypsin Pi\u2217Z allele is an independent risk factor for liver transplantation and death in patients with advanced chronic liver disease","volume":"4","author":"Balcar","year":"2022","journal-title":"JHEP Rep"},{"issue":"6","key":"10.1016\/j.jhepr.2025.101398_bib14","article-title":"Hepatic decompensation is accelerated in patients with cirrhosis and alpha-1 antitrypsin Pi\u2217MZ genotype","volume":"4","author":"Chen","year":"2022","journal-title":"JHEP Rep"},{"issue":"6","key":"10.1016\/j.jhepr.2025.101398_bib15","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1002\/lt.25057","article-title":"Heterozygosity for the alpha-1-antitrypsin Z allele in cirrhosis is associated with more advanced disease","volume":"24","author":"Schaefer","year":"2018","journal-title":"Liver Transpl"},{"issue":"4","key":"10.1016\/j.jhepr.2025.101398_bib16","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1056\/NEJMc2314292","article-title":"Liver transplantation","volume":"390","author":"Kappe","year":"2024","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.jhepr.2025.101398_bib17","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1002\/lt.25393","article-title":"Heterozygosity for the alpha-1-antitrypsin Z allele in cirrhosis is associated with more advanced disease","volume":"25","author":"Meister","year":"2019","journal-title":"Liver Transpl"},{"issue":"2","key":"10.1016\/j.jhepr.2025.101398_bib18","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.cld.2021.01.003","article-title":"Prevention of first decompensation in advanced chronic liver disease","volume":"25","author":"Mandorfer","year":"2021","journal-title":"Clin Liver Dis"},{"issue":"6","key":"10.1016\/j.jhepr.2025.101398_bib19","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1056\/NEJMoa2205416","article-title":"Fazirsiran for liver disease associated with alpha(1)-antitrypsin deficiency","volume":"387","author":"Strnad","year":"2022","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.jhepr.2025.101398_bib20","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1053\/j.gastro.2024.06.028","article-title":"Fazirsiran for adults with alpha-1 antitrypsin deficiency liver disease: a phase 2 placebo controlled trial (SEQUOIA)","volume":"167","author":"Clark","year":"2024","journal-title":"Gastroenterology"},{"issue":"10","key":"10.1016\/j.jhepr.2025.101398_bib21","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1111\/apt.17967","article-title":"Review article: new developments in biomarkers and clinical drug development in alpha-1 antitrypsin deficiency-related liver disease","volume":"59","author":"Loomba","year":"2024","journal-title":"Aliment Pharmacol Ther"},{"issue":"4","key":"10.1016\/j.jhepr.2025.101398_bib22","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.jhep.2021.12.022","article-title":"Baveno VII - renewing consensus in portal hypertension","volume":"76","author":"de Franchis","year":"2022","journal-title":"J Hepatol"},{"issue":"2","key":"10.1016\/j.jhepr.2025.101398_bib23","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/liv.12623","article-title":"New reliability criteria for transient elastography increase the number of accurate measurements for screening of cirrhosis and portal hypertension","volume":"35","author":"Schwabl","year":"2015","journal-title":"Liver Int"},{"issue":"7","key":"10.1016\/j.jhepr.2025.101398_bib24","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1053\/j.gastro.2013.02.042","article-title":"Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis","volume":"144","author":"Moreau","year":"2013","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.jhepr.2025.101398_bib25","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.jhep.2014.06.012","article-title":"Development and validation of a prognostic score to predict mortality in patients with acute-on-chronic liver failure","volume":"61","author":"Jalan","year":"2014","journal-title":"J Hepatol"},{"issue":"446","key":"10.1016\/j.jhepr.2025.101398_bib26","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","article-title":"A proportional hazards model for the subdistribution of a competing risk","volume":"94","author":"Fine","year":"1999","journal-title":"J Am Stat Assoc"},{"issue":"11","key":"10.1016\/j.jhepr.2025.101398_bib27","doi-asserted-by":"crossref","first-page":"3424","DOI":"10.1177\/0962280220921889","article-title":"A tutorial on frailty models","volume":"29","author":"Balan","year":"2020","journal-title":"Stat Methods Med Res"},{"issue":"6","key":"10.1016\/j.jhepr.2025.101398_bib28","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1016\/j.jhep.2018.08.005","article-title":"Clinical and histologic features of adults with alpha-1 antitrypsin deficiency in a non-cirrhotic cohort","volume":"69","author":"Clark","year":"2018","journal-title":"J Hepatol"},{"issue":"4","key":"10.1016\/j.jhepr.2025.101398_bib29","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/j.jhep.2021.11.022","article-title":"Alpha-1 antitrypsin deficiency: a re-surfacing adult liver disorder","volume":"76","author":"Fromme","year":"2022","journal-title":"J Hepatol"},{"issue":"5","key":"10.1016\/j.jhepr.2025.101398_bib30","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.jhep.2023.12.028","article-title":"Prognostic performance of non-invasive tests for portal hypertension is comparable to that of hepatic venous pressure gradient","volume":"80","author":"Jachs","year":"2024","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhepr.2025.101398_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/S0168-8278(24)01996-2","article-title":"TOP-141 Longitudinal assessment of individuals with homozygous alpha-1 antitrypsin deficiency (Pi\u2217ZZ genotype) provides evidence for clinical patient management","volume":"80","author":"Fromme","year":"2024","journal-title":"J Hepatol"},{"issue":"3","key":"10.1016\/j.jhepr.2025.101398_bib32","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.jhep.2017.10.020","article-title":"Clinical states of cirrhosis and competing risks","volume":"68","author":"D'Amico","year":"2018","journal-title":"J Hepatol"},{"issue":"17","key":"10.1016\/j.jhepr.2025.101398_bib33","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1056\/NEJMoa2029349","article-title":"Prospective study of outcomes in adults with nonalcoholic fatty liver disease","volume":"385","author":"Sanyal","year":"2021","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.jhepr.2025.101398_bib34","doi-asserted-by":"crossref","first-page":"2276","DOI":"10.1016\/j.cgh.2021.10.023","article-title":"Decompensation in advanced nonalcoholic fatty liver disease may occur at lower hepatic venous pressure gradient levels than in patients with viral disease","volume":"20","author":"Bassegoda","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"5","key":"10.1016\/j.jhepr.2025.101398_bib35","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/j.jhep.2024.05.033","article-title":"Hepatic venous pressure gradient predicts risk of hepatic decompensation and liver-related mortality in patients with MASLD","volume":"81","author":"Paternostro","year":"2024","journal-title":"J Hepatol"},{"issue":"12","key":"10.1016\/j.jhepr.2025.101398_bib36","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1002\/lt.23744","article-title":"Outcomes for recipients of liver transplantation for alpha-1-antitrypsin deficiency\u2013related cirrhosis","volume":"19","author":"Carey","year":"2013","journal-title":"Liver Transpl"},{"issue":"2","key":"10.1016\/j.jhepr.2025.101398_bib37","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.cld.2016.12.008","article-title":"Liver transplantation in alpha-1 antitrypsin deficiency","volume":"21","author":"Clark","year":"2017","journal-title":"Clin Liver Dis"},{"issue":"4","key":"10.1016\/j.jhepr.2025.101398_bib38","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.03200-2021","article-title":"Cancer risk in severe alpha-1-antitrypsin deficiency","volume":"60","author":"Hiller","year":"2022","journal-title":"Eur Respir J"},{"issue":"3","key":"10.1016\/j.jhepr.2025.101398_bib39","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1136\/gutjnl-2020-321375","article-title":"Alpha-1 antitrypsin governs alcohol-related liver disease in mice and humans","volume":"70","author":"Grander","year":"2021","journal-title":"Gut"},{"issue":"2","key":"10.1016\/j.jhepr.2025.101398_bib40","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.cgh.2023.08.038","article-title":"Alpha-1 antitrypsin augmentation and the liver phenotype of adults with alpha-1 antitrypsin deficiency (genotype Pi\u2217ZZ)","volume":"22","author":"Fromme","year":"2024","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.jhepr.2025.101398_bib41","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.jhep.2020.11.048","article-title":"The systemic inflammation hypothesis: towards a new paradigm of acute decompensation and multiorgan failure in cirrhosis","volume":"74","author":"Arroyo","year":"2021","journal-title":"J Hepatol"},{"issue":"3","key":"10.1016\/j.jhepr.2025.101398_bib42","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1007\/s12072-022-10473-x","article-title":"Biomarkers of hepatocellular synthesis in patients with decompensated cirrhosis","volume":"17","author":"Gurbuz","year":"2023","journal-title":"Hepatol Int"},{"issue":"11","key":"10.1016\/j.jhepr.2025.101398_bib43","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1111\/apt.17945","article-title":"Von Willebrand factor for outcome prediction within different clinical stages of advanced chronic liver disease","volume":"59","author":"Dominik","year":"2024","journal-title":"Aliment Pharmacol Ther"},{"issue":"4","key":"10.1016\/j.jhepr.2025.101398_bib44","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.jhep.2016.05.027","article-title":"Sustained virologic response to interferon-free therapies ameliorates HCV-induced portal hypertension","volume":"65","author":"Mandorfer","year":"2016","journal-title":"J Hepatol"},{"issue":"6","key":"10.1016\/j.jhepr.2025.101398_bib45","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1016\/j.jhep.2022.08.025","article-title":"Non-invasive tests for clinically significant portal hypertension after HCV cure","volume":"77","author":"Semmler","year":"2022","journal-title":"J Hepatol"},{"issue":"5","key":"10.1016\/j.jhepr.2025.101398_bib46","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/j.jhep.2020.11.021","article-title":"Clinical outcomes following DAA therapy in patients with HCV-related cirrhosis depend on disease severity","volume":"74","author":"Krassenburg","year":"2021","journal-title":"J Hepatol"},{"issue":"4","key":"10.1016\/j.jhepr.2025.101398_bib47","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.jhep.2021.11.025","article-title":"HCC risk stratification after cure of hepatitis C in patients with compensated advanced chronic liver disease","volume":"76","author":"Semmler","year":"2022","journal-title":"J Hepatol"},{"issue":"9","key":"10.1016\/j.jhepr.2025.101398_bib48","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.1016\/j.cgh.2022.11.033","article-title":"Alcohol abstinence improves prognosis across all stages of portal hypertension in alcohol-related cirrhosis","volume":"21","author":"Hofer","year":"2023","journal-title":"Clin Gastroenterol Hepatol"}],"container-title":["JHEP Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589555925000758?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589555925000758?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T20:11:39Z","timestamp":1762632699000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589555925000758"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":48,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S2589555925000758"],"URL":"https:\/\/doi.org\/10.1016\/j.jhepr.2025.101398","relation":{},"ISSN":["2589-5559"],"issn-type":[{"value":"2589-5559","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Severe alpha-1 antitrypsin deficiency is associated with a higher risk of complications after first decompensation than other aetiologies of cirrhosis","name":"articletitle","label":"Article Title"},{"value":"JHEP Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhepr.2025.101398","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V. on behalf of European Association for the Study of the Liver (EASL).","name":"copyright","label":"Copyright"}],"article-number":"101398"}}